$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization 원문보기

Journal of liver cancer = 대한간암학회지, v.21 no.1, 2021년, pp.97 - 103  

Noh, Minho (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea) ,  Kim, Beom Kyung (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea) ,  Kim, Seung Up (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea)

Abstract AI-Helper 아이콘AI-Helper

Optimal treatment strategies for patients with advanced hepatocellular carcinoma (HCC) is yet to be determined. Herein, we present a case of advanced HCC with tumor invasion into the right anterior portal vein and right hepatic vein where complete response (CR) was achieved via a multidisciplinary a...

주제어

참고문헌 (20)

  1. 1 Chan SL Chong CCN Chan AWH Poon DMC Chok KS Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016 World J Gastroenterol 2016 22 7289 7300 27621575 

  2. 2 Díaz-González Á Reig M Bruix J Treatment of hepatocellular carcinoma Dig Dis 2016 34 597 602 27332893 

  3. 3 Moriguchi M Aramaki T Nishiofuku H Sato R Asakura K Yamaguchi K Sorafenib versus hepatic arterial infusion chemotherapy as initial treatment for hepatocellular carcinoma with advanced portal vein tumor thrombosis Liver Cancer 2017 6 275 286 29234631 

  4. 4 Yoon SM Ryoo BY Lee SJ Kim JH Shin JH An JH Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial JAMA Oncol 2018 4 661 669 29543938 

  5. 5 Duffy AG Ulahannan SV Makorova-Rusher O Rahma O Wedemeyer H Pratt D Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma J Hepatol 2017 66 545 551 27816492 

  6. 6 Colagrande S Inghilesi AL Aburas S Taliani GG Nardi C Marra F Challenges of advanced hepatocellular carcinoma World J Gastroenterol 2016 22 7645 7659 27678348 

  7. 7 Kim BK Kim DY Byun HK Choi HJ Beom SH Lee HW Efficacy and safety of liver-directed concurrent chemoradiotherapy and sequential sorafenib for advanced hepatocellular carcinoma: a prospective phase 2 trial Int J Radiat Oncol Biol Phys 2020 107 106 115 32084526 

  8. 8 Han S Lee HW Park JY Kim SU Kim DY Ahn SH Appraisal of long-term outcomes of liver-directed concurrent chemoradiotherapy for hepatocellular carcinoma with major portal vein invasion J Hepatocell Carcinoma 2020 7 403 412 33365287 

  9. 9 Salem R Gabr A Riaz A Mora R Ali R Abecassis M Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience Hepatology 2018 68 1429 1440 29194711 

  10. 10 Sangro B Gardini AC Radioembolisation in hepatocellular carcinoma: principles of management Cross T Palmer DH Liver cancers: from mechanisms to management Cham Springer International Publishing 2019 139 152 

  11. 11 Pawlik TM Poon RT Abdalla EK Zorzi D Ikai I Curley SA Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma Arch Surg 2005 140 450 457 discussion 457–458 15897440 

  12. 12 Hermanek P Hendson DE Hutter RVP Sobin LH TNM supplement 1993: a commentary on uniform use Heidelberg Springer-Verlag 1993 1 142 

  13. 13 Edeline J Crouzet L Campillo-Gimenez B Rolland Y Pracht M Guillygomarc’h A Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis Eur J Nucl Med Mol Imaging 2016 43 635 643 26455499 

  14. 14 Schiro BJ Amour ES Harnain C Gandhi RT Management of high hepatopulmonary shunts in the setting of Y90 radioembolization Tech Vasc Interv Radiol 2019 22 58 62 31079711 

  15. 15 Theysohn JM Schlaak JF Müller S Ertle J Schlosser TW Bockisch A Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration J Vasc Interv Radiol 2012 23 949 952 22720895 

  16. 16 Cha H Yoon HI Lee IJ Koom WS Han KH Seong J Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma J Radiat Res 2013 54 1069 1077 23633620 

  17. 17 Leung TW Lau WY Ho SK Ward SC Chow JH Chan MS Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors Int J Radiat Oncol Biol Phys 1995 33 919 924 7591903 

  18. 18 Mokdad AA Singal AG Yopp AC Advances in local and systemic therapies for hepatocellular cancer Curr Oncol Rep 2016 18 9 26769114 

  19. 19 Hendrickson PG Olson M Luetkens T Weston S Han T Atanackovic D The promise of adoptive cellular immunotherapies in hepatocellular carcinoma Oncoimmunology 2020 9 1673129 32002284 

  20. 20 Takayama T Sekine T Makuuchi M Yamasaki S Kosuge T Yamamoto J Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet 2000 356 802 807 11022927 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로